PAROMOMYCIN sulfate, eq. 375mg/ml base, 2ml, amp

STD DINJPARO1A-

Valid Article

Former Code(s): -X
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
6.5.2 - Antileishmaniasis medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
A07AA06
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

See Related

Add article to list

   

Add Kit To Wishlist

   

PAROMOMYCIN

Full Name

Aminosidine

Therapeutic Action

Aminoglycoside antibiotic with anti-leishmanial activity

Indications

Visceral leishmaniasis and post-kala azar dermal leishmaniasis in East Africa region, in combination with pentavalent antimonial

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Must be given as IM injection.

Each 2-ml ampoule contains 750 mg paromomycin sulfate equivalent to 375 mg/ml paromomycin base.

Storage

  • Below 25°C - Protect from sunlight
  • Do not freeze.